Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia

Details for Australian Patent Application No. 2005259961 (hide)

Owner Board of Regents, The University of Texas System

Inventors Matalon, Reuben; Matalon, Ofer

Agent Fisher Adams Kelly

Pub. Number AU-B-2005259961

PCT Pub. Number WO2006/004719

Priority 60/589,710 21.07.04 US; 60/583,089 25.06.04 US

Filing date 25 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 17 May 2012

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/004719 Priority application(s): WO2006/004719

17 May 2012 Application Accepted

  Published as AU-B-2005259961

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259962-Reusable fitting for tubing

2005259958-Amelioration of drug-induced toxicity